, Volume 12, Issue 2, pp 254–264 | Cite as

Factors influencing the outcome of microsurgical transsphenoidal surgery for pituitary adenomas: A study on 184 patients

  • Kostas I. LampropoulosEmail author
  • George Samonis
  • Panagiotis Nomikos
Research paper


OBJECTIVE: Evaluation of factors influencing the outcome of microsurgical transsphenoidal surgery in patients harbouring pituitary adenomas as well as of the efficacy and safety of this procedure. DESIGN: A total of 184 consecutive patients with pituitary adenomas, undergoing microsurgical transsphenoidal resection of their lesions from March 2004 to June 2011, were prospectively studied. Extent of tumour resection and disease remission were defined according to recently established radiological and hormonal consensus criteria. RESULTS: The study included 97 nonfunctioning and 87 functioning adenomas. A gross-total removal, as documented on postoperative imaging, was achieved in 67.4% of all patients. Residual tumour after surgery was detected in 37.1% of patients with nonfunctioning adenomas. The remission rates for patients with functioning adenomas, as documented by the last endocrinological evaluation, were 54.9% for growth hormone-secreting, 69.5% for adrenocorticotropin hormone-secreting, 72.7% for prolactin-secreting and 100% for thyroid-stimulating hormone-secreting, with two recurrences in patients with Cushing’s disease. Multivariate analysis showed that factors influencing surgical outcome were cavernous sinus invasion, large tumour diameter (≥25 mm) and reoperation for the nonfunctioning adenomas, and cavernous sinus invasion as well as large tumour diameter (≥25 mm) for the functioning adenomas. In the latter cohort, predictors for endocrinological remission were maximum tumour diameter (≤20 mm) and reoperation. Post-operative complications were present in 3.3% of the cases. One patient developed epistaxis, two hemorrhage at the surgical field, one postoperative rhinorrhea, one postoperative permanent diabetes insipidus and one postoperative panhypopituitarism. CONCLUSIONS: Microsurgical transsphenoidal surgery is an effective and safe treatment in all patients with pituitary adenomas, except for prolactinomas responsive to medical therapy.

Key words

Outcome Pituitary adenoma Transsphenoidal microsurgery 


  1. 1.
    Burrow GN, Wortzman G, Rewcastle NB, Holgate RC, Kovacs K, 1981 Microadenomas of the pituitary and abnormal sellar tomograms in an unselected autopsy series. N Engl J Med 304: 156–158.CrossRefGoogle Scholar
  2. 2.
    Asa SL, 1989 Tumors of the pituitary gland. In: third series (ed) Atlas of tumor pathology, Armed Forces Institute of Pathology, Washington DC: Fascicle 22.Google Scholar
  3. 3.
    Molitch ME, 1999 Medical treatment of prolactinomas. Endocrinol Metab Clin North Am 28: 143–169.CrossRefGoogle Scholar
  4. 4.
    Losa M, Picozzi P, Motta M, Valle M, Franzin A, Mortini P, 2011 The role of radiation therapy in the management of non-functioning pituitary adenomas. J Endocrinol Invest: 34: 623–629.PubMedGoogle Scholar
  5. 5.
    Mortini P, Losa M, Barzaghi R, Boari N, Giovanalli M, 2005 Results of transsphenoidal surgery in a large series of patients with pituitary adenoma. Neurosurgery 56: 1222–1233.CrossRefGoogle Scholar
  6. 6.
    Melmed S, Colao A, Barkan A, et al, 2009 Guidelines for acromegaly management: an update. J Clin Endocrinol Metab 94: 1509–1517.CrossRefGoogle Scholar
  7. 7.
    Nimsky C, von Keller B, Ganslandt O, Fahlbush R, 2006 Intraoperative high-field magnetic resonance imaging in transsphenoidal surgery of hormonally inactive pituitary macroadenomas. Neurosurgery 59: 105–114.CrossRefGoogle Scholar
  8. 8.
    Buchfelder M, Fahlbusch R, 2002 The classic transsphenoidal approach for resection of pituitary tumors. Operat Techn Neurosurg 5: 210–217.CrossRefGoogle Scholar
  9. 9.
    Dehdashti AR, Ganna A, Karabatsou K, Gentili F, 2008 Pure endoscopic endonasal approach for pituitary adenomas: early surgical results in 200 patients and comparison with previous microsurgical series. Neurosurgery 62: 1006–1015.CrossRefGoogle Scholar
  10. 10.
    Knosp E, Steiner E, Kitz K, Matula C, 1993 Pituitary adenomas with invasion of the cavernous sinus space: Magnetic resonance imaging classification compared with surgical findings. Neurosurgery 33: 610–617.PubMedGoogle Scholar
  11. 11.
    Lissett CA, Shalet SM, 2000 Management of pituitary tumours; strategy for investigation and follow-up. Horm Res 53: 65–70.PubMedGoogle Scholar
  12. 12.
    Giustina A, Chanson P, Bronstein MD, et al, 2010 A consensus on criteria for cure of acromegaly. J Clin Endocrinol Metab 95: 3141–3148.CrossRefGoogle Scholar
  13. 13.
    Arnaldi G, Angeli A, Atkinson AB, et al, 2003 Diagnosis and complications of Cushing’s syndrome: a consensus statement. J Clin Endocrinol Metab 88: 5593–5602.CrossRefGoogle Scholar
  14. 14.
    Casanueva FF, Molitch ME, Schlechte JA, et al, 2006 Guidelines of the Pituitary Society for the diagnosis and management of prolactinomas. Clin Endocrinol (Oxf) 65: 265–273.CrossRefGoogle Scholar
  15. 15.
    Shou XF, Li SQ, Wang YF, Zhao Y, Jia PF, Zhou LF, 2005 Treatment of pituitary adenomas with a transsphenoidal approach. Neurosurgery 56: 249–256.CrossRefGoogle Scholar
  16. 16.
    Losa M, Mortini P, Barzaghi R, et al, 2008 Early results of surgery in patients with nonfunctioning pituitary adenoma and analysis of the risk of tumor recurrence. J Neurosurg 108: 525–532.CrossRefGoogle Scholar
  17. 17.
    Ebersold MJ, Quast LM, Laws ER Jr, Scheithauer B, Randall RV, 1986 Long-term results in transsphenoidal removal of nonfunctioning pituitary adenomas. J Neurosurg 64: 713–719.CrossRefGoogle Scholar
  18. 18.
    Marazuela M, Astigarraga B, Vicente A, et al, 1994 Recovery of visual and endocrine function following transsphenoidal surgery of large nonfunctioning pituitary adenomas. J Endocrinol Invest 17: 703–707.CrossRefGoogle Scholar
  19. 19.
    Nomikos P, Ladar C, Fahlbusch R, Buchfelder M, 2004 Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas — a study on 721 patients. Acta Neurochir (Wien) 146: 27–35.CrossRefGoogle Scholar
  20. 20.
    Wilson CB, Dempsey LC, 1978 Transsphenoidal microsurgical removal of 250 pituitary adenomas. J Neurosurg 48: 13–22.CrossRefGoogle Scholar
  21. 21.
    Jain AK, Gupta AK, Pathak A, Bhansali A, Bapuraj JR, 2008 Endonasal transsphenoidal pituitary surgery: is tumor volume a key factor in determining outcome? Am J Otolaryngol 29: 48–50.CrossRefGoogle Scholar
  22. 22.
    Zhang X, Fei Z, Zhang J, et al, 1999 Management of nonfunctioning pituitary adenomas with suprasellar extensions by transsphenoidal microsurgery. Surg Neurol 52: 380–385.CrossRefGoogle Scholar
  23. 23.
    Wichers-Rother M, Hoven S, Kristof RA, Bliesener N, Stoffel-Wagner B, 2004 Non-functioning pituitary adenomas: endocrinological and clinical outcome after transsphenoidal and transcranial surgery. Exp Clin Endocrinol Diabetes 112: 323–327.CrossRefGoogle Scholar
  24. 24.
    Harris PE, Afshar F, Coates P, et al, 1989 The effects of transsphenoidal surgery on endocrine function and visual fields in patients with functionless pituitary tumours. Q J Med 265: 417–427.Google Scholar
  25. 25.
    Greenman Y, Ouaknine G, Veshchev I, Reider-Groswasser II, Segev Y, Stern N, 2003 Postoperative surveillance of clinically non-functioning pituitary macroadenomas: markers of tumor quiescence and regrowth. Clin Endocrinol (Oxf) 58: 763–769.CrossRefGoogle Scholar
  26. 26.
    Chang EF, Zada G, Kim S, et al, 2008 Long-term recurrence and mortality after surgery and adjuvant radiotherapy for non-functional pituitary adenomas. J Neurosurg 108: 736–745.CrossRefGoogle Scholar
  27. 27.
    Losa M, Mortini P, Barzaghi R, Franzin A, Giovanelli M, 2001 Endocrine inactive and gonadotroph adenomas: diagnosis and management. J Neurooncol 54: 167–177.CrossRefGoogle Scholar
  28. 28.
    Park P, Chandler WF, Barkan AL, 2004 The role of radiation therapy after surgical resection of nonfunctional pituitary macroadenomas. Neurosurgery 55: 100–106.CrossRefGoogle Scholar
  29. 29.
    Pollock BE, Cochran J, Natt N, et al, 2008 γ-Knife radiosurgery for patients with nonfunctioning pituitary adenomas: results from a 15-year experience. Int J Radiat Oncol Biol Phys 70: 1325–1329.CrossRefGoogle Scholar
  30. 30.
    Sheehan JP, Kondziolka D, Flickinger J, Lunsford LD, 2002 Radiosurgery for residual or recurrent nonfunctioning pituitary adenoma. J Neurosurg 97: 408–414.CrossRefGoogle Scholar
  31. 31.
    Sheehan JP, Niranjan A, Sheehan JM, et al, 2005 Stereotactic radiosurgery for pituitary adenomas: an intermediate review of its safety, efficacy, and role in the neurosurgical treatment armamentarium. J Neurosurg 102: 678–691.CrossRefGoogle Scholar
  32. 32.
    Petrossians P, Borges-Martins L, Espinoza C, et al, 2005 Gross total resection or debulking of pituitary adenomas improves hormonal control of acromegaly by somatostatin analogs. Eur J Endocrinol 152: 61–66.CrossRefGoogle Scholar
  33. 33.
    Colao A, Attanasio R, Pivonello R, et al, 2006 Partial surgical removal of growth hormone-secreting pituitary tumors enhances the response to somatostatin analogs in acromegaly. J Clin Endocrinol Metab 91: 85–92.CrossRefGoogle Scholar
  34. 34.
    Abe T, Ludecke DK, 2001 Effects of preoperative octreotide treatment on different subtypes of 90 GH-secreting pituitary adenomas and outcome in one surgical centre. Eur J Endocrinol 145: 137–145.CrossRefGoogle Scholar
  35. 35.
    Nomikos P, Buchfeder M, Fahlbusch R, 2005 The outcome of surgery in 668 patients with acromegaly using current criteria of biochemical cure. Eur J Endocrinol 152(3): 379–387.CrossRefGoogle Scholar
  36. 36.
    Kaltsas GA, Isidori AM, Florakis D, et al, 2001 Predictors of the outcome of surgical treatment in acromegaly and the value of the mean growth hormone day curve in assessing postoperative disease activity. J Clin Endocrinol Metab 86: 1645–1652.CrossRefGoogle Scholar
  37. 37.
    Shimon I, Cohen ZR, Ram Z, Hadani M, 2001 Transsphenoidal surgery for acromegaly: endocrinological follow-up of 98 patients. Neurosurgery 48: 1239–1243.PubMedGoogle Scholar
  38. 38.
    Beauregard C, Truong U, Hardy J, Serri O, 2003 Longterm outcome and mortality after transsphenoidal adenomectomy for acromegaly. Clin Endocrinol (Oxf) 58: 86–91.CrossRefGoogle Scholar
  39. 39.
    Abosch A, Tyrrell JB, Lamborn KR, Hannegan LT, Applebury CB, Wilson CB, 1998 Transsphenoidal microsurgery for growth hormone-secreting pituitary adenomas: initial outcome and longterm results. J Clin Endocrinol Metab 83: 3411–3418.CrossRefGoogle Scholar
  40. 40.
    Gao R, Isoda H, Tanaka T, et al, 2001 Dynamic gadolinium-enhanced MR imaging of pituitary adenomas: usefulness of sequential sagittal and coronal plane images. Eur J Radiol 39: 139–146.CrossRefGoogle Scholar
  41. 41.
    Markus JB, Franchetto AA, Goh R, 1999 The use of intravenous contrast in postoperative MR imaging of pituitary macroadenomas. Clin Immunol 23: 5–10.Google Scholar
  42. 42.
    Kremer P, Forsting M, Hamer J, Sartor K, 1996 MR imaging of residual tumor tissue after transsphemoidal surgery of hormone-inactive pituitary macroadenomas; a prospective study. Acta Neurochir 65: 27–30.Google Scholar
  43. 43.
    Candrina R, Gasparotti R, Galli G, Rukgerri G, Bollati A, 1991 Comparison between computed tomography and magnetic resonance imaging in the postoperative evaluation of acromegalic patients. Recenti Prog Med 82: 509–513.PubMedGoogle Scholar
  44. 44.
    Baleriaux D, Jacquemin C, Lemort M, 1990 Magnetic resonance imaging of the pituitary gland and the sella turcica region. Normal and pathological aspect. Ann Endocrinol (Paris) 51: 173–180.Google Scholar
  45. 45.
    Connor SE, Deasy NP, 2002 MRI appearances of the sphenoid sinus at the late follow-up of transsphenoidal surgery for pituitary macroadenoma. Australas Radiol 46: 33–40.CrossRefGoogle Scholar
  46. 46.
    Dina TS, Feaster SH, Laws Jr ER, Davis DO, 1993 MR of the pituitary gland postsurgery; serial MR studies following transsphenoidal resection. AJNR Am J Neuroradiol 14: 763–769.PubMedGoogle Scholar
  47. 47.
    Hofmann BM, Hlavac M, Martinez R, Buchfelder M, Müller OA, Fahlbusch R, 2008 Long-term results after microsurgery for Cushing disease: experience with 426 primary operations over 35 years. J Neurosurg 108: 9–18.CrossRefGoogle Scholar
  48. 48.
    Rees DA, Hanna FW, Davies JS, Mills RG, Vafidis J, Scanlon MF, 2002 Long-term follow-up results of transsphenoidal surgery for Cushing’s disease in a single centre using strict criteria for remission. Clin Endocrinol 56: 541–251.CrossRefGoogle Scholar
  49. 49.
    Bakiri F, Tatai S, Aouali R, et al, 1996 Treatment of Cushing’s disease by transsphenoidal, pituitary microsurgery: prognosis, factors and long-term follow-up. J Endocrinol Invest 19: 572–580.CrossRefGoogle Scholar
  50. 50.
    Barbetta L, Dall’Asta C, Tomei G, Locatelli M, Giovanelli M, Ambrosi B, 2001 Assessment of cure and recurrence after pituitary surgery for Cushing’s disease. Acta Neurochir (Wien) 143: 477–482.CrossRefGoogle Scholar
  51. 51.
    Blevins LS Jr, Christy JH, Khajavi M, Tindall GT, 1998 Outcomes of therapy for Cushing’s disease due to adrenocorticotropin-secreting pituitary macroadenomas. J Clin Endocrinol Metab 83: 63–67.Google Scholar
  52. 52.
    Bochicchio D, Losa M, Buchfelder M, 1995 Factors influencing the immediate and late outcome of Cushing’s disease treated by transsphenoidal surgery: a retrospective study by the European Cushing’s Disease Survey Group. J Clin Endocrinol Metab 80: 3114–3120.Google Scholar
  53. 53.
    Charpentier G, de Plunkett T, Jedynak P, 1985 Surgical treatment of prolactinomas. Short- and long-term results, prognostic factors. Horm Res 22: 222–227.CrossRefGoogle Scholar
  54. 54.
    Scanlon MF, Peters JR, Thomas JP, et al, 1985 Management of selected patients with hyperprolactinaemia by partial hypophysectomy. Br Med J (Clin Res Ed) 291: 1547–1550.CrossRefGoogle Scholar
  55. 55.
    Maira G, Anile C, De Marinis L, Barbarino A, 1989 Prolactin-secreting adenomas: Surgical results and long-term follow-up. Neurosurgery 24: 736–743.CrossRefGoogle Scholar
  56. 56.
    Nomikos P, Buchfelder M, Fahlbusch R, 2001 Current management of prolactinomas. J Neurooncol 54: 139–150.CrossRefGoogle Scholar
  57. 57.
    Ciric I, Ragin A, Baumgartner C, Pierce D, 1997 Complications of transsphenoidal surgery: Results of a national survey, review of the literature, and personal experience. Neurosurgery 40: 225–236.CrossRefGoogle Scholar

Copyright information

© Hellenic Endocrine Society 2013

Authors and Affiliations

  • Kostas I. Lampropoulos
    • 1
    Email author
  • George Samonis
    • 2
  • Panagiotis Nomikos
    • 1
  1. 1.Department of Neurosurgery and Gamma Knife RadiosurgeryHygeia HospitalMarousi, AthensGreece
  2. 2.Division of MedicineUniversity of CreteHeraklion, CreteGreece

Personalised recommendations